Ongoing Studies
We are currently enrolling participants in a variety of clinical studies designed to advance medical knowledge and improve patient care. Explore our current studies below to see if you qualify.
Chronic Obstructive Pulmonary Disease (COPD)
This study investigates if inhaled COPD medicines can also protect you from serious heart events, such as heart attacks and heart failure, as well as reducing COPD flare- ups.
- Men and Woman
- Ages 40 to 80 years old
- Current or former smokers
- Evidence of Cardiovascular risk factors (Hypertension, Diabetes, Chronic Kidney disease, High Cholesterol, Obesity)
COMPENSATION UP TO: $1,400
Chronic Heart Failure subjects with iron deficiency
This study investigates that correcting iron deficiency in patients with heart failure may increase resistance or resilience to a broad range of problems that cause hospitalizations.
- Men and Women
- Age ≥18 years old
- Medical History of heart failure
- Hemoglobin ≤13 g/dL for women and ≤14 g/dL for men
COMPENSATION UP TO: TBD
Atrial Fibrillation (AFib) Study
This study evaluates whether investigational treatments (REGN7508 and REGN9933) may reduce the risk of bleeding events compared to apixaban in patients with atrial fibrillation. The goal is to improve safety outcomes while effectively managing AFib.
- Men and Women
- Age ≥18 years old
- Diagnosed with Atrial Fibrillation (AFib) or atrial flutter
COMPENSATION UP TO: $1,000
Chronic Obstructive Pulmonary Disease (COPD) Study – EMBARK
This study evaluates the efficacy and safety of tezepelumab in adults with moderate to very severe COPD. The goal is to reduce exacerbations and improve respiratory outcomes in patients with a history of disease worsening.
- Men and Women
- Age 40 to 80 years old
- Diagnosed with moderate to severe COPD
- History of ≥ 2 moderate OR ≥ 1 severe COPD exacerbations in the last 12 months
COMPENSATION UP TO: $3,600
Interested in participating in clinical research but don't see a study that fits?